SCHEMBL22318124

SCHEMBL22318124

CCN1CCC2C1CN2CC

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ HCRTR1 O43613 1/20 0.30
▸ HCRTR2 O43614 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13751271 0.86 ALDH1A1 (0.35) SMN1; SMN2
SCHEMBL13751274 0.84 CYP2D6 (0.34) —
SCHEMBL22301662 0.81 CHRM2 (0.30) —
SCHEMBL27072955 0.81 — —
SCHEMBL13751280 0.80 ALDH1A1 (0.37) SMN1; SMN2
SCHEMBL25089471 0.79 SMN1; SMN2 (0.31) SMN1; SMN2
SCHEMBL27281048 0.79 — —
SCHEMBL27280968 0.79 — —
SCHEMBL22952346 0.78 CHRM2 (0.31) —
SCHEMBL24338026 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020160198-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2020-08-06 — — WO disclosed
Send feedback